Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Take Five: ECB, earnings galore and 'Freedom Day'

Published 07/16/2021, 04:38 AM
Updated 07/16/2021, 02:51 PM
© Reuters. FILE PHOTO: The headquarters of the European Central Bank (ECB) in Frankfurt, Germany, March 12, 2016. REUTERS/Kai Pfaffenbach

(Reuters) - 1/ ECB DAY

Two weeks after unveiling its closely anticipated strategy review, the ECB will face questions at its Thursday meeting on what its new 2% inflation target might mean for policy.

If the ECB is serious about boosting inflation to 2% (versus close to but below 2% before), surely hefty bond buying will continue for some time? Doves are already arguing that to remain credible, the ECB needs to highlight its room for manoeuvre.

The hawks though are already pressing for tapering stimulus as the economy rebounds. Perhaps concern about a resurgent coronavirus hurting growth will allow ECB chief Christine Lagarde to find common ground at Thursday's meeting. A quiet summer may be around the corner for most, not the ECB.

Reuters poll graphic on euro zone economic outlook: https://fingfx.thomsonreuters.com/gfx/polling/yxmvjzxdjvr/ECB%20final%20July%202021.PNG

2/ OUTLIER

    Many developed economies are pondering tapering emergency stimulus but China has just added more money to its banking system and there's an outside chance the benchmark loan prime rate (LPR) set by Chinese banks could be lowered as early as Tuesday.

    The dual-track economy is seeing supply-side headwinds, growth and exports are peaking, while consumer spending flags. An uncertain regulatory environment for big firms and standoffs with the United States are weighing on investor sentiment.

    After the recent cut to banks' reserve requirements and data showing the economy lost some steam in the second quarter, markets expect a bit of monetary easing even as fiscal policy stays tight.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Graphic: China GDP & rates - https://fingfx.thomsonreuters.com/gfx/mkt/yzdpxlzzgpx/Pasted%20image%201626342515440.png

3/ FIRST FAANG

    The second-quarter U.S. earnings season kicked off with stronger-than-expected numbers from banks, now it's the turn of the tech and consumer giants, including streaming heavyweight Netflix (NASDAQ:NFLX).

    A darling of last year's stay-at-home trade, Netflix shares are up just 2% this year as investors have shifted to stocks which benefit as the economy reopens. Lower production of TV shows and movies during COVID-19 have dented subscriber growth.

Signs U.S. economic growth has peaked have nevertheless been boosting the tech stocks that led markets for much of the past decade so Netflix shares too have rallied of late.

The coming days also see quarterly results from the likes of Johnson & Johnson (NYSE:JNJ), Coca-Cola (NYSE:KO), Twitter and Intel (NASDAQ:INTC).

Graphic: "FAANG" stocks in 2021 - https://graphics.reuters.com/USA-STOCKS/NETFLIX/rlgpdrywxpo/chart.png

4/ AS GOOD AS IT GETS?

Europe's results season is starting in earnest, meanwhile, and corporate earnings are expected to have more than doubled in Q2.

Profits of the 600 biggest listed European companies are seen surging 110% between April and June, according to Refinitiv I/B/E/S data.

Yet investors fear this is as good as it will get and that volatility could follow once peak momentum is hit - earnings growth rates of roughly 34% and 28% are expected for the last two quarters of 2021.

There is also the COVID-19 upsurge to contend with. Bourses in Europe, as on Wall Street, are near record highs but any risk of renewed lockdowns could easily knock them off that perch.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Graphic: European earnings - https://fingfx.thomsonreuters.com/gfx/mkt/jznpnyaqbvl/Pasted%20image%201626250481323.png

5/ FREEDOM OR RISK

The British media dubs it "Freedom Day," Germany describes it as a "highly risky experiment". So, who's right about July 19, the day Britain drops its COVID-19-linked activity curbs and mandatory mask-wearing?

Britain's blistering vaccine campaign had made the pound one of this year's best performing G10 currencies, lifted shares in UK hospitality and retail firms and spurred hopes of a swift economic rebound.

But an upsurge in the Delta variant and forecasts for Britain's COVID caseload to reach 100,000 a day by the end of August are stirring unease. Bonds are benefiting from a rush to safety while European travel shares are down 8% in the past month.

Friday's July Purchasing Managers' Index releases may reflect the impact of rising infections on activity. With the likes of Israel and Holland backtracking on reopening plans and Germany retaining curbs until vaccinations rise, just how long Britons enjoy their freedom from lockdown remains to be seen.

Graphic: UK COVID cases - https://fingfx.thomsonreuters.com/gfx/mkt/oakpedkoqvr/Pasted%20image%201626295027784.png

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.